MedTrace Logo

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

NCT06350734 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2026-04-17

No results posted yet for this study

Summary

This study evaluates the effect of bladder cancer treatment on quality of life.

Conditions

  • Stage 0a Bladder Cancer AJCC v8
  • Stage 0is Bladder Cancer AJCC v8
  • Stage I Bladder Cancer AJCC v8
  • Stage II Bladder Cancer AJCC v8
  • Stage IIIA Bladder Cancer AJCC v8

Interventions

OTHER

Non-Interventional Study

Non-Interventional Study

Sponsors & Collaborators

Principal Investigators

  • Mark D. Tyson, M.D., M.P.H. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2029-01-31
Completion
2029-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06350734 on ClinicalTrials.gov